Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
MLP Saglik Hizmetleri A.S. (MPARK.IS)
TRY413.00
-2.50 (-0.60%)
TR IST Healthcare Medical - Care Facilities
Address
Otakçilar Caddesi Flatofis Istanbul, No: 78 3450
Istanbul, TR
Istanbul, TR
CEO
Muharrem Usta
Website
mlpcare.com
IPO
2018-02-13
ISIN TREMLPC00021
Description
MLP Saglik Hizmetleri AS operates private medical institutions. Its brands include Medical Park, Liv Hospital, VM Medical Park, and Istinye University Hospital. The company was founded by Muharrem Usta and Adem Elbasi in 1993 and is headquartered in Istanbul, Turkey.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
TRY413.00
-2.50 (-0.60%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
719.0K
Beta
0.79
Float Shares
55.81M
Free Float %
29.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.92% | +6.45% | +11.74% | +4.49% | +50.23% | +30.09% | +41.83% | +624.74% | +2,002.80% | +2,540.00% | +2,540.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
413.00
DCF (Unlevered)
4,297.97
+940.7%
DCF (Levered)
3,719.42
+800.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
86% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 5 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.83
Grey zone
Piotroski F-Score
5 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+38.8% ★ Q1'26: +38.3% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+13.4% Q1'26: +42.6% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+0.1% Q1'26: -2.4% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+19.0% ★ Q1'26: +18.6% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+13.9% ★ Q1'26: +18.1% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%-6.3% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1.33× ★ Q1'26: 1.09× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.13B
est: 3.11B (+0.7%)
|
3.70B
est: 3.72B (-0.4%)
|
4.01B
est: 4.05B (-0.9%)
|
5.80B
est: 5.35B (+8.4%)
|
9.84B
est: 9.14B (+7.6%)
|
22.45B
est: 25.77B (-12.9%)
|
39.69B
est: 39.88B (-0.5%)
|
55.09B
est: 54.31B (+1.4%)
|
74.11B
72.95B – 75.23B
+36.5% YoY
|
87.54B
83.39B – 91.69B
+18.1% YoY
|
108.48B
103.83B – 113.12B
+23.9% YoY
|
| EBITDA |
395.43M
est: 891.24M (-55.6%)
|
850.43M
est: 1.07B (-20.2%)
|
858.50M
est: 1.16B (-26.1%)
|
1.30B
est: 1.53B (-15.2%)
|
2.36B
est: 2.62B (-9.8%)
|
9.08B
est: 7.69B (+18.1%)
|
13.90B
est: 11.91B (+16.7%)
|
15.08B
est: 16.21B (-7.0%)
|
22.13B
21.78B – 22.46B
+36.5% YoY
|
26.13B
24.89B – 27.37B
+18.1% YoY
|
32.39B
31.00B – 33.77B
+23.9% YoY
|
| EBIT |
27.62M
est: 702.81M (-96.1%)
|
551.32M
est: 840.67M (-34.4%)
|
606.68M
est: 915.82M (-33.8%)
|
933.18M
est: 1.21B (-22.8%)
|
1.92B
est: 2.07B (-7.2%)
|
7.54B
est: 6.03B (+25.2%)
|
11.18B
est: 9.33B (+19.9%)
|
10.49B
est: 12.70B (-17.4%)
|
17.33B
17.06B – 17.59B
+36.5% YoY
|
20.47B
19.50B – 21.44B
+18.1% YoY
|
25.37B
24.28B – 26.45B
+23.9% YoY
|
| Net Income |
-127.65M
est: -70.16M (-81.9%)
|
36.25M
est: -11.69M (+410.0%)
|
64.93M
est: 93.49M (-30.5%)
|
290.42M
est: 296.18M (-1.9%)
|
1.62B
est: 1.12B (+44.0%)
|
4.53B
est: 4.32B (+5.0%)
|
5.21B
est: 5.32B (-2.1%)
|
5.54B
est: 5.67B (-2.4%)
|
7.50B
7.18B – 7.82B
+32.2% YoY
|
9.82B
9.40B – 10.25B
+31.0% YoY
|
12.54B
12.00B – 13.08B
+27.7% YoY
|
| SGA |
131.88M
est: 139.24M (-5.3%)
|
145.16M
est: 166.56M (-12.8%)
|
114.62M
est: 181.44M (-36.8%)
|
222.20M
est: 239.39M (-7.2%)
|
513.68M
est: 409.29M (+25.5%)
|
1.50B
est: 1.43B (+5.0%)
|
1.50B
est: 2.21B (-32.1%)
|
4.52B
est: 3.01B (+50.1%)
|
4.11B
4.05B – 4.17B
+36.5% YoY
|
4.86B
4.63B – 5.09B
+18.1% YoY
|
6.02B
5.76B – 6.28B
+23.9% YoY
|
| EPS |
-0.62
est: -0.34 (-80.1%)
|
0.17
est: -0.06 (+396.3%)
|
0.31
est: 0.46 (-32.4%)
|
1.40
est: 1.45 (-3.7%)
|
7.78
est: 5.66 (+37.6%)
|
22.23
est: 22.59 (-1.6%)
|
25.57
est: 27.88 (-8.3%)
|
28.99
est: 30.72 (-5.6%)
|
39.27
37.57 – 40.95
+27.8% YoY
|
51.44
49.21 – 53.65
+31.0% YoY
|
65.67
62.83 – 68.49
+27.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
6.94B
OE per share TTM
36.31
Owner's Yield
7.39%
Maintenance CapEx ratio
74.65%
Maint CapEx / Avg PPE
56.6%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 65 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI Turkey ETF TUR | 1.09% | 2.22M | 0.59% |
| 2 | iShares Ageing Population UCITS ETF AGED.L | 0.07% | 623.6K | 0.40% |
| 3 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.06% | 352.1K | 0.55% |
| 4 | JPMorgan Diversified Return Emerging Markets Equity ETF JPEM | 0.05% | 206.9K | 0.44% |
| 5 | FlexShares Morningstar Emerging Markets Factor Tilt Index Fund TLTE | 0.05% | 185.7K | 0.58% |
| 6 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.05% | 168.4K | 0.74% |
| 7 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.04% | 155.2K | 0.72% |
| 8 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.02% | 58.4K | 0.35% |
| 9 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.01% | 45.4K | 0.56% |
| 10 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.01% | 79.8K | 0.44% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
810.5K
Shares Outstanding
191.01M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Adem Elbasi | Founder & Chief Operations Coordinator And Director | — | — |
| Burcu Ozturk | Chief Financial Officer | — | female |
| Deniz Can Yucel | Strategy and Investor Relations Director | — | — |
| Gürkan Caglioglu | IT & Digital Transformation Coordinator | — | — |
| Hakan Özcan | Chief Process Improvement Coordinator | — | male |
| Hikmet Cavus | Chief Strategy & Performance Coordinator | — | — |
| Izzet Usta | Founder | — | male |
| Muharrem Usta | Chief Executive Officer & Chairman | — | — |
| Nurgul Durustkan Elbasi | Founder | — | female |
| Saliha Usta | Founder | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MPARK.IS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
